Ryan Specialty (NYSE:RYAN – Get Free Report) and Roadzen (NASDAQ:RDZN – Get Free Report) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.
Risk & Volatility
Ryan Specialty has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Roadzen has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500.
Earnings & Valuation
This table compares Ryan Specialty and Roadzen”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ryan Specialty | $2.28 billion | 7.55 | $61.04 million | $0.64 | 102.98 |
| Roadzen | $50.04 million | 1.34 | -$99.67 million | ($3.00) | -0.33 |
Insider & Institutional Ownership
84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 24.7% of Roadzen shares are owned by institutional investors. 11.1% of Ryan Specialty shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Ryan Specialty and Roadzen’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ryan Specialty | 10.21% | 48.08% | 6.57% |
| Roadzen | -287.82% | -31,166.20% | -221.81% |
Analyst Recommendations
This is a summary of recent ratings and price targets for Ryan Specialty and Roadzen, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ryan Specialty | 1 | 5 | 5 | 0 | 2.36 |
| Roadzen | 0 | 0 | 2 | 0 | 3.00 |
Ryan Specialty currently has a consensus price target of $70.33, indicating a potential upside of 6.72%. Roadzen has a consensus price target of $8.00, indicating a potential upside of 716.33%. Given Roadzen’s stronger consensus rating and higher possible upside, analysts clearly believe Roadzen is more favorable than Ryan Specialty.
Summary
Ryan Specialty beats Roadzen on 11 of the 14 factors compared between the two stocks.
About Ryan Specialty
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.
About Roadzen
Roadzen, Inc., an insurtech company, provides various insurance products in the United States and internationally. It offers insurance as a service platform, including Via, which enables fleets, carmakers, and insurers to inspect a vehicle using computer vision; Global Distribution Network that enables the configuration, customer quote, payment, and administration of any insurance policy with any insurance carrier as the underwriter; xClaim, which enables digital, touchless, and real-time resolution of claims; StrandD, a digital, real-time dispatch, and tracking for roadside assistance and first notice of loss during accident claims; Good Driving that enables insurers and fleets to recognize drivers, train drivers, and build usage based insurance programs; and Drivebuddy AI, which provides driver-assistance capabilities. The company also provides insurance distribution platform that enables product creation and underwriting, re-insurer backing, and API exchange; and distribution, pre-inspection assistance, telematics, and roadside assistance. In addition, it offers insurance broker services. Roadzen, Inc. was founded in 2015 and is based in Burlingame, California.
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
